METTL3 antagonizes 5FU chemotherapy and confers drug resistance in colorectal carcinoma.
Int J Oncol
; 61(3)2022 09.
Article
in En
| MEDLINE
| ID: mdl-35856434
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Antineoplastic Agents
Language:
En
Journal:
Int J Oncol
Year:
2022
Type:
Article